1,360
Participants
Start Date
April 22, 2020
Primary Completion Date
December 10, 2020
Study Completion Date
January 9, 2021
Hydroxychloroquine
oral self administered tablet
Placebo oral tablet
oral self administered tablet
Hospital for Special Surgery, New York
Columbia University, Irving Medical Center, New York
Weill Cornell Medicine, New York
University of Pittsburgh School of Medicine, Pittsburgh
Temple University Hospital, Philadelphia
Johns Hopkins, Baltimore
Wake Forest Baptist Health Sciences, Winston-Salem
University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
University of Florida Jacksonville, Jacksonville
University of Florida, Gainesville
Advent Health, Orlando
University of Miami Florida, Miami
University of South Florida, Tampa
University of Florida Health Central Florida, Leesburg
Clinical Trials Center of Middle Tennessee, Franklin
Vanderbilt University Medical Center, Nashville
The Ohio State University Wexner Medical Center, Columbus
University of Michigan, Ann Arbor
University of Iowa, Iowa City
Marshfield Clinic Health System, Marshfield
Allina Health, Minneapolis
Mayo Clinic Hospital Rochester, Rochester
Northwestern Medicine, Chicago
Rush University, Chicago
University of Missouri-Columbia, Columbia
University of Kansas Medical Center, Kansas City
University of Nebraska Medical Center, Omaha
University Medical Center New Orleans, New Orleans
Ochsner Clinic Foundation, New Orleans
University of Texas Southwestern Medical Center, Dallas
Baylor Scott & White Medical Center-Temple, Temple
Children's Hospital Colorado/University of Colorado Denver, Aurora
Seattle Children's Hospital, Seattle
Patient-Centered Outcomes Research Institute
OTHER
Adrian Hernandez
OTHER